• Chairman’s Letter

    Decisive step to create a pure Life Science company

    In 2014, just a year after our 150th anniversary, Bayer opened up a new chapter in its history: we initiated the decisive step toward becoming a pure Life Science company. In the future we will focus our entire innovative capability on designing molecules and solutions that improve human health or nutrition.


Science For A Better Life

Our Mission

With its products and services Bayer strives to benefit people and improve their quality of life.


Supervisory Board

Werner Wenning, Chairman of the Supervisory Board:

“The deliberations of the Supervisory Board focused on questions relating to the strategies and business activities of the Group as a whole and of the subgroups, as well as personnel decisions.”


Executive Council

New Board Member

Since September 2014 Johannes Dietsch is a new Bayer AG Board of Management member and responsible for finance.


Download Center

Online annexes

Enter the relevant code given in the printed version of the Annual Report

Last updated: February 26, 2015  Copyright © Bayer AG